Mild Paravalvular Leak May Pose an Increased Thrombogenic Risk in Transcatheter Aortic Valve Replacement (TAVR) Patients-Insights from Patient Specific In Vitro and In Silico Studies
Open Access
- 1 February 2023
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 10 (2) , 188
Abstract
In recent years, the treatment of aortic stenosis with TAVR has rapidly expanded to younger and lower-risk patients. However, persistent thrombotic events such as stroke and valve thrombosis expose recipients to severe clinical complications that hamper TAVR’s rapid advance. We presented a novel methodology for establishing a link between commonly acceptable mild paravalvular leak (PVL) levels through the device and increased thrombogenic risk. It utilizes in vitro patient-specific TAVR 3D-printed replicas evaluated for hydrodynamic performance. High-resolution µCT scans are used to reconstruct in silico FSI models of these replicas, in which multiple platelet trajectories are studied through the PVL channels to quantify thrombogenicity, showing that those are highly dependent on patient-specific flow conditions within the PVL channels. It demonstrates that platelets have the potential to enter the PVL channels multiple times over successive cardiac cycles, increasing the thrombogenic risk. This cannot be reliably approximated by standard hemodynamic parameters. It highlights the shortcomings of subjectively ranked PVL commonly used in clinical practice by indicating an increased thrombogenic risk in patient cases otherwise classified as mild PVL. It reiterates the need for more rigorous clinical evaluation for properly diagnosing thrombogenic risk in TAVR patients.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (BRP U01EB026414, STTR Phase II R42-HL134418)
- National Heart, Lung, and Blood Institute (BRP U01EB026414, STTR Phase II R42-HL134418)
- Center for Biotechnology: a New York State Center for Advanced Technology, New York State Department of Economic Development (BRP U01EB026414, STTR Phase II R42-HL134418)
This publication has 40 references indexed in Scilit:
- The development of transcatheter aortic valve replacement (TAVR)Global Cardiology Science and Practice, 2017
- Lagrangian methods for blood damage estimation in cardiovascular devices - How numerical implementation affects the resultsExpert Review of Medical Devices, 2016
- Total ellipse of the heart valve: the impact of eccentric stent distortion on the regional dynamic deformation of pericardial tissue leaflets of a transcatheter aortic valve replacementJournal of The Royal Society Interface, 2015
- Device thrombogenicity emulation: A novel methodology for optimizing the thromboresistance of cardiovascular devicesJournal of Biomechanics, 2013
- Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve ReplacementNew England Journal of Medicine, 2012
- Device Thrombogenicity Emulation: A Novel Method for Optimizing Mechanical Circulatory Support Device ThromboresistancePLOS ONE, 2012
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- Device Thrombogenicity Emulator (DTE) − Design optimization methodology for cardiovascular devices: A study in two bileaflet MHV designsJournal of Biomechanics, 2010
- Flow‐induced Platelet Activation and Damage Accumulation in a Mechanical Heart Valve: Numerical StudiesArtificial Organs, 2007
- Towards optimization of the thrombogenic potential of blood recirculating cardiovascular devices using modeling approachesExpert Review of Medical Devices, 2006